Latest filing published 03 Aug 2026 for HERON THERAPEUTICS, INC. /DE/. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Ira Duarte is a declared insider at 2 companies (finance chief); the most frequent names are Heron Therapeutics, Inc. /DE/ and TerrAscend Corp. In total, 28 filings cover trades dated from 22 June 2023 to 31 July 2026.
The open-market record is one-sided, with 1 purchase worth €70k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 8 share grants and 19 option exercises.
The latest filing, published on 3 August 2026, reports an option exercise in Heron Therapeutics, Inc. /DE/. The most recent open-market purchase was published on 17 November 2023, 1,066 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 28 declarations